Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2023 | 29 | 0.820 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2023 | 27 | 0.800 |
Why?
|
| Oral Ulcer | 1 | 2019 | 6 | 0.620 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2019 | 12 | 0.620 |
Why?
|
| Granuloma | 1 | 2019 | 18 | 0.620 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 98 | 0.570 |
Why?
|
| Immunity, Innate | 2 | 2024 | 233 | 0.550 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 1 | 2013 | 2 | 0.400 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 128 | 0.400 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2013 | 20 | 0.400 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 169 | 0.390 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2013 | 84 | 0.390 |
Why?
|
| Interferon-gamma | 1 | 2013 | 109 | 0.380 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 195 | 0.370 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 236 | 0.360 |
Why?
|
| Hodgkin Disease | 1 | 2024 | 11 | 0.220 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2024 | 39 | 0.220 |
Why?
|
| Adaptive Immunity | 1 | 2024 | 38 | 0.220 |
Why?
|
| Interleukin-1beta | 1 | 2024 | 46 | 0.220 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2024 | 112 | 0.210 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2023 | 6 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 170 | 0.200 |
Why?
|
| Diagnostic Imaging | 1 | 2023 | 70 | 0.190 |
Why?
|
| Merkel cell polyomavirus | 1 | 2022 | 2 | 0.190 |
Why?
|
| Polyomavirus Infections | 1 | 2022 | 7 | 0.190 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2022 | 13 | 0.190 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2020 | 1 | 0.170 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2020 | 9 | 0.170 |
Why?
|
| Opportunistic Infections | 1 | 2020 | 17 | 0.170 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 28 | 0.160 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 147 | 0.160 |
Why?
|
| Neutropenia | 1 | 2020 | 41 | 0.160 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2020 | 7 | 0.160 |
Why?
|
| Cryptococcus neoformans | 1 | 2020 | 34 | 0.160 |
Why?
|
| Receptors, Androgen | 1 | 2020 | 26 | 0.160 |
Why?
|
| Sepsis | 1 | 2020 | 87 | 0.160 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 84 | 0.150 |
Why?
|
| Mouth Mucosa | 1 | 2019 | 16 | 0.150 |
Why?
|
| Humans | 8 | 2024 | 28998 | 0.150 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 302 | 0.120 |
Why?
|
| Animals | 5 | 2020 | 10715 | 0.120 |
Why?
|
| Mice | 4 | 2020 | 4815 | 0.100 |
Why?
|
| Bacteroidaceae Infections | 1 | 2013 | 3 | 0.100 |
Why?
|
| Porphyromonas gingivalis | 1 | 2013 | 7 | 0.100 |
Why?
|
| Serine | 1 | 2013 | 51 | 0.100 |
Why?
|
| Enterotoxins | 1 | 2013 | 22 | 0.100 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2013 | 34 | 0.100 |
Why?
|
| Multiple Organ Failure | 1 | 2013 | 31 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 88 | 0.100 |
Why?
|
| NF-kappa B | 1 | 2013 | 191 | 0.090 |
Why?
|
| Lymphocyte Activation | 1 | 2013 | 210 | 0.090 |
Why?
|
| Cytokines | 1 | 2014 | 452 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 1661 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2013 | 1022 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2013 | 876 | 0.080 |
Why?
|
| Aged | 1 | 2019 | 5608 | 0.080 |
Why?
|
| Female | 3 | 2024 | 15690 | 0.070 |
Why?
|
| Reed-Sternberg Cells | 1 | 2024 | 1 | 0.060 |
Why?
|
| Monocytes | 1 | 2024 | 135 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 287 | 0.050 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2022 | 1 | 0.050 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2022 | 3 | 0.050 |
Why?
|
| Macrophages | 1 | 2024 | 306 | 0.050 |
Why?
|
| Male | 3 | 2024 | 13983 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 148 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2020 | 25 | 0.040 |
Why?
|
| Fever | 1 | 2020 | 31 | 0.040 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2020 | 32 | 0.040 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2020 | 9 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 67 | 0.040 |
Why?
|
| Headache | 1 | 2020 | 35 | 0.040 |
Why?
|
| Graft vs Host Disease | 1 | 2020 | 32 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2020 | 103 | 0.040 |
Why?
|
| Biopsy | 1 | 2020 | 208 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 379 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 843 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 1351 | 0.030 |
Why?
|
| Brain | 1 | 2020 | 770 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1511 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 47 | 0.020 |
Why?
|
| Ligands | 1 | 2013 | 178 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2013 | 72 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 202 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2013 | 221 | 0.020 |
Why?
|
| Lipids | 1 | 2013 | 220 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 701 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 7428 | 0.020 |
Why?
|